Uniplan Investment Counsel, Inc. - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 26 filers reported holding SEELOS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Uniplan Investment Counsel, Inc. ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,342
+72.5%
1,123,101
-0.3%
0.10%
+78.2%
Q1 2023$778
-2.6%
1,126,815
-4.3%
0.06%
-3.5%
Q4 2022$799
-100.0%
1,177,510
-52.6%
0.06%
-70.9%
Q3 2022$2,559,000
+50.5%
2,485,327
-0.6%
0.20%
+66.1%
Q2 2022$1,700,000
+29.8%
2,499,211
+59.7%
0.12%
+53.2%
Q1 2022$1,310,000
-48.2%
1,564,605
+0.9%
0.08%
-45.4%
Q4 2021$2,527,000
-32.2%
1,550,359
+0.3%
0.14%
-38.4%
Q3 2021$3,726,000
-8.9%
1,546,136
-0.2%
0.23%
-5.0%
Q2 2021$4,090,000
-46.4%
1,549,539
+1.3%
0.24%
-50.7%
Q1 2021$7,630,000
+150.7%
1,529,115
-20.6%
0.49%
+135.1%
Q4 2020$3,044,000
+59.9%
1,927,036
-5.2%
0.21%
+56.4%
Q3 2020$1,904,000
+39.0%
2,033,020
+49.9%
0.13%
+40.0%
Q2 2020$1,370,000
+35.1%
1,356,435
-34.4%
0.10%
+25.0%
Q1 2020$1,014,000
+13.9%
2,069,121
+211.4%
0.08%
+43.4%
Q4 2019$890,000
+47.4%
664,477
+0.9%
0.05%
+39.5%
Q3 2019$604,000
-60.2%
658,460
-4.9%
0.04%
-60.4%
Q2 2019$1,516,000692,6230.10%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 508,000$249,0000.10%
1492 Capital Management LLC 150,000$74,0000.09%
Uniplan Investment Counsel, Inc. 2,069,121$1,014,0000.08%
ARDSLEY ADVISORY PARTNERS LP 70,000$34,0000.01%
Spark Investment Management LLC 35,210$17,0000.01%
TOCQUEVILLE ASSET MANAGEMENT L.P. 191,000$94,0000.00%
WealthPLAN Partners, LLC 20,000$15,0000.00%
Procyon Advisors, LLC 2,500$1,0000.00%
Renaissance Technologies 1,078,379$529,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders